A carregar...
Ageing is a risk factor in imatinib mesylate cardiotoxicity
AIMS: Chemotherapy-induced heart failure is increasingly recognized as a major clinical challenge. Cardiotoxicity of imatinib mesylate, a highly selective and effective anticancer drug belonging to the new class of tyrosine kinase inhibitors, is being reported in patients, some progressing to conges...
Na minha lista:
| Publicado no: | Eur J Heart Fail |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4238824/ https://ncbi.nlm.nih.gov/pubmed/24504921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.58 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|